Goh Keow Lin 4

What Happened

• Goh Keow Lin, a director of Tevogen Bio Holdings, was granted 40,000 restricted shares on July 10, 2026. The transaction is reported as an award/grant (code A) at a reported price of $0.00, meaning no cash was exchanged at grant.

Key Details

• Transaction date: 2026-07-10; transaction type: Award/Grant (A).
• Shares granted: 40,000; reported acquisition price: $0.00 (no cash paid).
• Shares owned after transaction: Not disclosed in the filing.
• Vesting/conditions (footnote): The grant is restricted stock under Tevogen’s 2024 Omnibus Incentive Plan and vests in three equal installments upon the earlier of (a) the 1st anniversary and the company having $50M aggregate revenue since the grant, (b) the 2nd anniversary and $100M aggregate revenue, and (c) the 3rd anniversary and $150M aggregate revenue — provided the director remains in service on each vesting date.
• Filing timeliness: Report filed with a period/report date of 2026-07-10; no late filing indicated.

Context

• Restricted stock grants are compensation awards, not open-market purchases or sales; they do not require an immediate cash outlay and vest only if service and revenue milestones are met. Such grants align insider compensation with company performance but should not be read alone as a market sentiment signal.